Nutra Pharma Quick Ratio (NPHC) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Nutra Pharma Corp   (NPHC)

Nutra Pharma 's Quick Ratio

NPHC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Nutra Pharma 's Cash & cash equivalent grew by 578.43 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Nutra Pharma 's Quick Ratio to 0.01, above Nutra Pharma Corp average Quick Ratio.

Within Legal Cannabis industry 20 other companies have achieved higher Quick Ratio than Nutra Pharma in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 4598, from total ranking in the first quarter 2026 at 5587.

Explain Quick Ratio?
How much Cash & cash equivalents NPHC´s has?
What are NPHC´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NPHC/financial-strength
https://api.csimarket.com/api/v1/companies/NPHC/fundamentals
https://api.csimarket.com/api/v1/companies/NPHC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
NPHC Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 31.07 %
Y / Y Cash & cash equivalent Change 153.72 %
Quick Ratio MRQ 0.01
NPHC's Total Ranking # 4598
Seq. Current Liabilities Change 22.29 %
Seq. Cash & cash equivalent Change 578.43 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Legal Cannabis Industry # 21
Consumer Non Cyclical Sector # 162
Overall Market # 4363


Quick Ratio Statistics
High Average Low
0.08 0 0
(Jun 30 2019)   (Mar 31 2015)




Financial Statements
Nutra Pharma 's Current Liabilities $ 22 Millions Visit NPHC's Balance sheet
Nutra Pharma 's Cash & cash equivalent $ 0 Millions Visit NPHC's Balance sheet
Source of NPHC's Sales Visit NPHC's Sales by Geography


Cumulative Nutra Pharma 's Quick Ratio

NPHC's Quick Ratio for the trailling 12 Months

NPHC Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months 		(Dec 31 2025)
12 Months 		(Sep 30 2025)
12 Months 		(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 15.27 %
Y / Y Cash & cash equivalent TTM Growth 56.12 %
Quick Ratio TTM 0
Total Ranking TTM # 4164
Seq. Current Liabilities TTM Growth 7.51 %
Seq. Cash & cash equivalent TTM Growth 79.2 %

Quick ratio ranking by company, industry and sector >> Back to NPHC Financial Strength Comparisons >> Go to Compare NPHC Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the growth in Current Liabilities in the Q2 2026 to $21.70 millions, cumulative Quick Ratio